SMS Pharmaceuticals Invests Rs. 3 Crores in Subsidiary SMS Peptides, Increasing Stake to 99.98%

SMS Pharmaceuticals Ltd. has invested in its subsidiary, SMS Peptides Private Limited, by subscribing to its Rights Issue. The company has allotted 30,00,000 equity shares of Rs. 10/- each, amounting to Rs. 3,00,00,000/-. This investment has increased the company's holding in SMS Peptides from 93% to 99.98% of the equity share capital. SMS Peptides, a pharmaceutical company, is a subsidiary of SMS Pharmaceuticals and was incorporated in November 2024. The transaction is at arm's length and does not require any governmental or regulatory approvals. The subsidiary allotted the shares on 27.06.2025. The cost of acquisition is Rs. 3,00,00,000/- and the share price is Rs. 10/- each at par.